TwinBeech Capital’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$143K Buy
+10,000
New +$172K 0.03% 365

Other funds holding TRVI

TwinBeech Capital's TRVI Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 10,000 shares worth $143K. The stake represents 0.03% of the portfolio and ranks #365 among its holdings.

222 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • TwinBeech Capital held 10,000 shares of Trevi Therapeutics worth $143K as of Q3 2026.
  • Trevi Therapeutics was a new TwinBeech Capital position in Q3 2026.
  • Trevi Therapeutics made up 0.03% of TwinBeech Capital's portfolio in Q3 2026, its #365 holding.
  • 222 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.